J&J Biochemist Testifies Company Never Gave FDA Risperdal Safety Analysis It Knew About For Years

May 2015

New Brunswick Today reports: “In two lawsuits alleging that Johnson & Johnson’s antipsychotic drug Risperdal caused boys to grow female breasts, a biochemist for the company testified that the Food Drug Administration (FDA) was never given an internal analysis showing a link between the two.”